AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

(2010) Vedat Tiyerili et al.   BASIC RESEARCH IN CARDIOLOGY

Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration

(2010) A. Gupta et al.   Science Signaling

Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration

(2009) Marie-Laure Rives et al.   EMBO JOURNAL

Novel endogenous peptide agonists of cannabinoid receptors

(2009) Ivone Gomes et al.   FASEB JOURNAL

Reactive Nitrogen Species Switch on Early Extracellular Matrix Remodeling via Induction of MMP1 and TNFα

(2009) Raquel Urtasun et al.   GASTROENTEROLOGY

Renin-angiotensin system in the pathogenesis of liver fibrosis

(2009) Regina Maria Pereira et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

(2008) Won-il Jeong et al.   Cell Metabolism

Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3

(2008) Raphael Rozenfeld et al.   FASEB JOURNAL

Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor α, reduced glutathione, and transforming growth factor β-dependent mechanisms

(2008) Francisco Javier Cubero et al.   HEPATOLOGY

Endocannabinoids and the Control of Energy Homeostasis

(2008) George Kunos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of angiotensin II AT1 receptor activation in cardiovascular diseases

(2008) Sandrine Billet et al.   KIDNEY INTERNATIONAL

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

(2008) Scott L. Friedman   PHYSIOLOGICAL REVIEWS

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

(2008) George Kunos et al.   TRENDS IN PHARMACOLOGICAL SCIENCES